Table 4

Summary of outcomes after in vivo transfer of CML-14736 into histocompatible miniature swine

AnimalAge, moCoancestryPretreatmentImmunosuppressionTumor sourceOutcome
16354 (DD2, 10) 0.94 None None Cultured cells: IV, SC No growth 
16354 (DD2, 10) 0.94 None None Primary tissue: SC No growth 
16524 (DD4, G9) 1.5 0.87 500 cGy TBI None Cultured cells: IV, SC Tumor growth at SC sites and in lung 
16523 (DD4, G9) 1.5 0.87 300 cGy TBI None Cultured cells: IV, SC Tumor growth at SC sites only 
16526 (DD4, G9) 0.87 300 cGy TBI None Cultured cells: IV, SC Tumor growth at SC sites only 
16526 (DD4, G9) 0.87 300 cGy TBI None Passaged cells: SC Tumor growth 
16527 (DD4, G9) 0.87 100 cGy TBI None Cultured cells: IV, SC No growth 
16527 (DD4, G9) 0.87 100 cGy TBI None Passaged cells: SC No growth 
16525 (DD4, G9) 0.87 None CyA (30 d) Cultured cells: IV, SC No growth 
16525 (DD4, G9) 0.87 None CyA (30 d) Passaged cells: SC No growth 
AnimalAge, moCoancestryPretreatmentImmunosuppressionTumor sourceOutcome
16354 (DD2, 10) 0.94 None None Cultured cells: IV, SC No growth 
16354 (DD2, 10) 0.94 None None Primary tissue: SC No growth 
16524 (DD4, G9) 1.5 0.87 500 cGy TBI None Cultured cells: IV, SC Tumor growth at SC sites and in lung 
16523 (DD4, G9) 1.5 0.87 300 cGy TBI None Cultured cells: IV, SC Tumor growth at SC sites only 
16526 (DD4, G9) 0.87 300 cGy TBI None Cultured cells: IV, SC Tumor growth at SC sites only 
16526 (DD4, G9) 0.87 300 cGy TBI None Passaged cells: SC Tumor growth 
16527 (DD4, G9) 0.87 100 cGy TBI None Cultured cells: IV, SC No growth 
16527 (DD4, G9) 0.87 100 cGy TBI None Passaged cells: SC No growth 
16525 (DD4, G9) 0.87 None CyA (30 d) Cultured cells: IV, SC No growth 
16525 (DD4, G9) 0.87 None CyA (30 d) Passaged cells: SC No growth 

IV indicates intravenous; and SC, subcutaenous.

or Create an Account

Close Modal
Close Modal